You are here

P&T News

October 20

Chlamydia, gonorrhea, and syphilis take double-digit jumps
First new initial treatment of STS in more than 40 years
Desmopressin nasal spray gets ‘thumbs up,’ with reservations
Device bypasses expensive ‘clean rooms’

October 19

Treatment is limited to patients with specific EGFR mutations
Insoluble compound traps potassium ions
Therapy meets primary endpoint in phase 3 trial

October 18

Researchers suggests stronger regulatory oversight of endocrine-disrupting chemicals
Product will cost 15% less than the current wholesale acquisition cost of Remicade
Though declining in number, they’re particularly important in underserved areas
Funds intended for clinical studies evaluating drugs, biologics, medical devices, or medical foods

October 17

Penalty illustrates U.S. government’s emphasis on combating health care fraud
Investigational nerve growth factor antibody targets osteoarthritis and back pain
Combining immunotherapeutic treatments with antiestrogen drugs may extend survival
Clinicians advised that current tools underestimate fracture risk in these patients
Previously unexplained symptoms associated with multiple copies of a single gene